Got $2,000? Consider Buying These 2 Beaten-Down Cathie Wood Stocks at Your Own Risk
Cathie Wood's ARK Innovation ETF (NYSEMKT: ARKK) is down by more than 56% this year, and it might have further to fall. In that vein, two aspiring biomedical businesses are a bit worse for the wear of the bear market despite Cathie Wood's continued confidence in their success. 10X Genomics (NASDAQ: TXG) sells laboratory analyzer devices used to profile gene expression in cells.